Poster Presentations Session II
Poster Presentations Session II Sunday, 17 September 2017
POSTERS SET-UP: 7:45 - 8:00
POSTERS DISPLAY HOURS: 8:00 - 14:00
POSTER AUTHOR DISCUSSION: 13:00 - 14:00
POSTERS DISMANTLE: 14:00


Poster display locations are shown below the poster codes
HEALTH CARE USE & POLICY STUDIES - Consumer Role in Health Care
PHP1
A1
FACTORES ASOCIADOS A LA AUTOMEDICACIÓN EN USUARIOS DE BOTICAS Y FARMACIAS EN PERÚ: ANÁLISIS DE LA ENCUESTA DE SATISFACCIÓN DE LOS SERVICIOS DE SALUD (ENSUSALUD) 2015
Urrunaga-Pastor D1, Benites-Zapata VA2, Mezones-Holguín E3
1Sociedad Científica de Estudiantes de Medicina de la Universidad de San Martin de Porres, Universidad de San Martin de Porres, Lima, Perú., Lima, Peru, 2Centro de Investigación de Salud Pública, Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martin de Porres, Lima, Perú., Lima, Peru, 3Postgraduate School, Universidad San Ignacio de Loyola, Lima, Perú, Peru

PHP2
A2
Attitude and Perception of Pakistani Pharmacy students;a vision towards future Post Graduate Education
Iqbal A1, Iqbal MM2, Shahid H3, Sethi MH1, Ahmad T1
1COMSATS ABBOTTABAD, Abbottabad, Pakistan, 2Ayub Medical College Abbottabad, Abbottabad, Pakistan, 3Hazara University, Mansehra, Pakistan

HEALTH CARE USE & POLICY STUDIES - Diagnosis Related Group
PHP3
A3
CAMBIO EN LA CARGA DE ENFERMEDAD AJUSTADA POR RIESGO PARA UNA POBLACIÓN AFILIADA A UNA ASEGURADORA COLOMBIANA
Romero Prada ME1, Vivas Consuelo D2, Cruz AM3, Marino C4, Celis S5, Acero Acero G5
1Fundación Salutia, Bogotá, Colombia, 2Universitat Politècnica de València, Valencia, Spain, 3Coomeva EPS, Cali, Colombia, 4Coomeva, Bogotá, Colombia, 5Salutia Foundation - Research center in economy, management and health technologies., Bogota, Colombia

HEALTH CARE USE & POLICY STUDIES - Disease Management
PHP4
A4
IMPACTO ECONÓMICO EN LAS PATOLOGÍAS DE SALUD MENTAL, NEUROLÓGICAS Y DEMENCIAS EN COLOMBIA
Romero Prada ME1, Cruz AM2, Quinche G3, Leguizamo M4, Celis S4
1Fundación Salutia, Bogotá, Colombia, 2Coomeva EPS, Cali, Colombia, 3Coomeva Group, Cali, Colombia, 4Salutia Foundation - Research center in economy, management and health technologies., Bogota, Colombia

HEALTH CARE USE & POLICY STUDIES - Drug/Device/Diagnostic Use & Policy
PHP5
A5
HYDROGEN PEROXIDE AS A SUSTAINABLE ALTERNATIVE FOR STERILIZATION
Oliveira FM1, Junqueira Junior SM1, Luque A1, Oliveira D1, Cabra HA2
1Johnson & Johnson Medical Brazil, São Paulo, Brazil, 2Johnson & Johnson Medical, Miami, FL, USA

PHP6
A6
EVALTUATION OF THE NATIONAL DRUG FORMULARIUM AND ELECTRONIC CATALOG FOR THE INDONESIAN UHC
Thabrany H, Abidin Z
The National Social Security Council, Jakarta, Indonesia

PHP7
A7
ACCESS TO MEDICINES: DEVELOPING AN INDICATOR TO ASSESS THE IMPACT OF PUBLIC POLICIES
Garcia MM1, Guerra Junior AA2, Barbosa MM1, Alvares J1, Reis EA1, Acúrcio FA1
1College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil, 2Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

PHP8
A8
WITHDRAWN

PHP9
A9
EVALUATING THE USE OF CENTRAL NERVOUS SYSTEM STIMULANTS AMONG MEDICAL AND NON-MEDICAL STUDENTS
Ahmad M, Masood I, Umer D, Razzaq M, Baig U, Hassan F, Akram T
The Islamia University of Bahawalpur, Bahawalpur, Pakistan

PHP10
A10
INTERRUPTED TIME SERIES ANALYSIS EVALUATING THE IMPACT OF A PRO-GENERIC POLICY ON DRUG PRICING AND UTILIZATION IN ARGENTINA
Wilson L1, Yi EJ1, Lightwood J1, Lee B1, Garay U2
1University of California, San Francisco, San Francisco, CA, USA, 2Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina

HEALTH CARE USE & POLICY STUDIES - Equity and Access
PHP11
A11
HOW FAR EQUITY HAS BEEN ACHIEVED IN THE INDONESIAN UNIVERSAL HEALTH COVERAGE?
Thabrany H, Adawiyah E
The National Social Security Council, Jakarta, Indonesia

HEALTH CARE USE & POLICY STUDIES - Formulary Development
PHP12
A12
WILL PRIORITIZATION OF VACCINE INTRODUCTION LEAD TO A HIGHER RETURN OF INVESTMENT? THE CASE OF COLOMBIA
Connolly M1, Kotsopoulos N2, Van Vlaenderen I3, Standaert B4, Dort T5, Tovar J6
1University of Groningen, Groningen, The Netherlands, 2Health Policy Institute, Athens, Greece, 3CHESS in Health, Brussels, Belgium, 4GSK, Wavre, Belgium, 5Keyrus Management S.A. on behalf of GSK, Strombeek-Bever, Belgium, 6Universidad de Los Andes - Bogotá, Bogota, Colombia

HEALTH CARE USE & POLICY STUDIES - Health Care Costs & Management
PHP13
A13
TRANSSEXUAL’S SEX REASSIGMENT PROCESS IN BRAZILIAN NATIONAL HEALTH SYSTEM: WHERE ARE WE?
Amaral LM1, Amaral DM2, Fernandes RA1, Menezes LP1, Correa JS1, Teich V3
1Sense Company, Rio de Janeiro, Brazil, 2Coordenadoria Especial da Diversidade Sexual, Rio de Janeiro, Brazil, 3Sense Company, São Paulo, Brazil

PHP14
A14
EL IMPACTO ECONÓMICO DE LA COMORBILIDAD EN UN SISTEMA DE SALUD PRIVADO EN MÉXICO
Garza C, Ramírez MÁ
Vitamédica, Ciudad de México, Mexico

PHP15
WITHDRAWN

PHP16
A15
THE DEVELOPMENT OF DRUG PRICE INDEX FOR EACH HEALTH CARE SECTOR IN TAIWAN
Lin W1, Hsieh C2, Hsu YE3, Tan H1, Lu C4
1Chang Jung Christian University, Tainan, Taiwan, 2Oriental Institute of Technology, New Taipei City, Taiwan, 3Taipei Medical University, Taipei, Taiwan, 4Southern Taiwan University of Sience and Technology, Tainan, Taiwan

PHP17
A16
COST SAVING ANALYSIS OF ENCEPHALOGRAM BISPECTRAL INDEX MONITORING (BIS) DURING TEN DIFFERENT TYPES OF ELECTIVE SURGERIES IN COLOMBIA
Giraldo JC1, Benavides CA2, Orozco JJ3, Valencia J4, Lopez A5, Camacho EL5
1Fundación Cardioinfantil, Bogota, Colombia, 2Clinica Universitaria Colombia-Organizacion Sanitas, Bogota, Colombia, 3Medtronic PLC, Medellín, Colombia, 4Medtronic, Miami, FL, USA, 5Medtronic PLC, Bogota, Colombia

PHP18
A17
REVISÃO SISTEMÁTICA DAS DIRETRIZES DE ANÁLISE DE IMPACTO ORÇAMENTÁRIO
Rodrigues RF1, Silva DR2, Campolina AG2, Sartori AM3, Novaes HM4, De Soarez PC2
1Universidade de São Paulo e Hospital de Transplante Dr. Euryclides de Jesus Zerbini - SPDM, São Paulo, Brazil, 2Universidade de São Paulo, São Paulo, Brazil, 3Universidade de Sao Paulo, São Paulo, Brazil, 4Universidade de São Paulo, Sao Paulo, Brazil

PHP19
A18
MODELIZACIÓN ECONÓMICA DEL AJUSTE POR RIESGO DEL GASTO SANITARIO PER CÁPITA SEGUN MORBILIDAD EN LA COMUNIDAD VALENCIANA, ESPAÑA
Caballer-Tarazona V1, Vivas-Consuelo D1, Guadalajara MN1, Romero M2
1Politecnic University of Valencia, Valencia, Spain, 2Fundación Salutia, Bogotá D.C., Colombia

PHP20
B1
VALOR MONETARIO DE LAS MUERTES DE MOTOCICLISTAS EN COLOMBIA
Rosselli D
Pontificia Universidad Javeriana, Bogotá, Colombia

PHP21
B2
FATORES ASSOCIADOS AOS GASTOS COM IMAGENOLOGIA NO SISTEMA UNICO DE SAUDE BRASILEIRO
Liebel G, Dias PV, Chaoubah A
Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil

PHP22
B3
SUBSTANTIATION OF THE NATIONAL POLICY OF PRICING AND AVAILABILITY OF DRUGS
Nemchenko A, Nazarkina V, Simonian L, Simonian L
National University of Pharmacy, Kharkiv, Ukraine, Kharkiv, Ukraine

PHP23
B4
WITHDRAWN

PHP24
B5
PERCEPCIÓN DE LA COMPETENCIA EN EL MERCADO DE MEDICAMENTOS ESENCIALES Y HUÉRFANOS EN PANAMÁ.
Herrera Ballesteros VH, Niño Hall C, Conte E, Gomez B
Gorgas Memorial Institute of Health Studies, Panama, Panama

PHP25
B6
SELF-PERCEIVED HEALTH IN LATIN AMERICA: RESULTS FROM 2007-2008 GALLUP WORLD POLL
Duran D1, Aubert J1, Monsalves mJ1, Zarate V1, Kind P2
1Universidad San Sebastián, Santiago, Chile, 2HSE University, St. Petersburg, Russian Federation

PHP26
B7
DIFERENCIAS GEOGRÁFICAS EN LA SALUD AUTO-PERCIBIDA COMUNAL DE CHILE
Aubert J, Duran D, Monsalves mJ, Lopez F, Zarate V
Universidad San Sebastián, Santiago, Chile

PHP27
B8
O AUMENTO DA PRODUÇÃO CIENTÍFICA E A IMPORTÂNCIA DA BIBLIOTECONOMIA
Mascarenhas R, Fernandes RA, Vasconcellos JF, Amaral LM
Sense Company, Rio de Janeiro, Brazil

PHP28
B9
RADAR – AN IMPORTANT TOOL FOR HORIZON SCANNING DISSEMINATION IN BRAZIL
Gomes PT1, Teixeira Vidal A2, Souza A2
1Brazil Ministry of Health, BRASILIA, Brazil, 2Department of Management and Incorporation of Health Technology, National Committee for Health Technology Incorporation (CONITEC), Brazilian Ministry of Health, Brasília, Brazil

PHP29
B10
WITHDRAWN

PHP30
B11
ANÁLISIS DE VARIABILIDAD EN LOS PRECIOS DE SERVICIOS EN SALUD PARA COLOMBIA
Romero Prada ME1, Romero Y1, Ordoñez S2, Acero G3, Gallo D1, Celis S4
1Fundación Salutia, Bogotá, Colombia, 2Salutia Foundation, Bogotá, Colombia, 3Salutia Foundation- Research center in economy, management and health technologies., Bogota, Colombia, 4Salutia Foundation - Research center in economy, management and health technologies., Bogota, Colombia

PHP31
B12
CHARACTERISTICS AND COST BURDEN OF ADVERSE DRUG REACTIONS IN A TERTIARY HEALTH CARE HOSPITAL IN SOUTHERN CHILE.
Porma JL1, Yzoard M2, Cordova P3, Fernandez P1, Lopez M1, Morales F3, Villa L1
1Universidad de Concepción, Concepción, Chile, 2Hospital Regional de Concepción, Concepción, Chile, 3Facultad de Farmacia, Universidad de Concepción, Concepción, Chile

PHP32
B13
CUSTOS DIRETOS DE EVENTOS ADVERSOS IDENTIFICADOS EM UM HOSPITAL DE GRANDE PORTE NO BRASIL
van Keulen Md1, Chaoubah A1, Fernandes G2
1UFJF, Juiz de Fora, Brazil, 2Santa Casa de Misericórdia de Juiz de Fora, Juiz de Fora, Brazil

PHP33
B14
A SAÚDE DO TRABALHADOR EM QUESTÃO: ANÁLISE DO ABSENTEÍSMO E O PERFIL DOS ATESTADOS MÉDICOS EM UM HOSPITAL DE GRANDE PORTE NO CEARÁ
Viana A1, Viana JL2, Viana JF3, Reis HP4, Viana RM1
1UNIMED Fortaleza, Fortaleza, Brazil, 2UNICHRISTUS University, Fortaleza, Brazil, 3Lourenço Filho University, Fortaleza, Brazil, 4UFC, Fortaleza, Brazil

PHP34
B15
PRESCRIPTION WRITING ERRORS DETECTION BY PHARMACIST IN A PEDIATRIC WARD
Ahmed T1, Iqbal Q1, Ahmed S2, Minhas M1, Mehmood S2
1University of Balochistan, Quetta, Pakistan, 2Bolan Medical Complex Hospital, Quetta, Pakistan

PHP35
B16
EFETIVIDADE NA SOLICITAÇÃO DE EXAMES LABORATORIAIS NA ATENÇÃO BÁSICA
Yamaguchi MU1, Karpinski C2, Lopes TN2, Massuda EM3
1Instituto Cesumar de Ciência, Tecnologia e Inovação, Maringá, Brazil, 2Centro Universitário de Maringá, Maringá, Brazil, 3UniCesumar, MARINGÁ PR, Brazil

PHP36
B17
NATIONAL ADOPTION OF NEW IMMUNOSSUPRESANTS FOR SOLID ORGANS AND STEM CELLS TRANSPLANTATIONS
Trindade E1, Muller S2, Canuto Santos VC3, Carneiro D'albuquerque LA1, Buehler A4, Petramale C5
1University of São Paulo Medical School, São Paulo, Brazil, 2São Paulo State Health Secretariat, São Paulo, Brazil, 3Brazilian Ministry of Health, Brasília, Brazil, 4Hospital Alemão Osvaldo Cruz, São Paulo, Brazil, 5Department of Management and Incorporation of Health Technology, Ministry of Health of Brazil, Brasília, Brazil

PHP37
B18
ANÁLISIS DE LA RELACIONES DE MERCADO ENTRE EL SEGURO OBLIGATORIO Y EL SEGURO VOLUNTARIO PARA EL CASO COLOMBIANO.
Romero Prada ME1, Villegas J2, Pájaro A3, Celis S4
1Fundación Salutia, Bogotá, Colombia, 2Coomeva Group, Cali, Colombia, 3Salutia Foundation, Bogotá, Colombia, 4Salutia Foundation - Research center in economy, management and health technologies., Bogota, Colombia

PHP38
C1
APLICAÇÃO DA MCDA NAS TOMADAS DE DECISÃO SOBRE INVESTIMENTO EM SAÚDE – UMA REVISÃO SISTEMÁTICA
Salgado JB, Magliano CA, Santos M
Instituto Nacional de Cardiologia, Rio de Janeiro, Brazil

PHP39
C2
RETROSPECTIVE ANALYSIS OF THE USE OF INCREMENTAL COST-EFFECTIVENESS RATIO (ICER) IN TECHNOLOGY INCORPORATION IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS), 2012-2016, PERSPECTIVES AND CHALLENGES FOR THE BRAZILIAN CONTEXT
Yuba TY1, Novaes HM2, De Soárez PC1
1University of Sao Paulo, Sao Paulo, Brazil, 2Universidade de São Paulo, Sao Paulo, Brazil

HEALTH CARE USE & POLICY STUDIES - Health Care Research & Education
PHP40
C3
USES AND APPLICATIONS OF EQ-5D IN LATIN AMERICA & THE CARIBBEAN: SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS
Rey-Ares L1, Hernández-Vásquez A1, Irazola V1, Comande D1, Augustovski F2
1Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, 2Universidad de Buenos Aires, Buenos Aires, Argentina

PHP41
C4
ETHICAL REQUIREMENTS FOR THE CONDUCT OF DRUG UTILIZATION STUDIES IN LATIN AMERICA: A CROSS-SECTIONAL SURVEY
Bergamasco A1, Arredondo-Bisono T1, Castillon G2, Moride Y3
1YolaRx Consultants, Paris, France, 2YolaRx Consultants, Montreal, QC, Canada, 3Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada

PHP42
C5
EFECTIVIDAD DE LAS INTERVENCIONES EN CULTURA DE SEGURIDAD DEL PACIENTE EN LAS INSTITUCIONES HOSPITALARIAS: REVISIÓN SISTEMÁTICA
Gómez N1, Samacá D2, Sánchez N2, Eslava-Schmalbach J2
1Universidad Nacional de Colombia, Bogotá, Colombia, 2Sociedad Colombiana de Anestesiología y Reanimación, Bogotá, Colombia

HEALTH CARE USE & POLICY STUDIES - Health Technology Assessment Programs
PHP43
C6
AVALIAÇÃO ECONÔMICA DE TECNOLOGIAS NA ÁREA DE NUTRIÇÃO: APLICAÇÕES E LIMITAÇÕES PARA O CONTEXTO BRASILEIRO
Yuba TY1, Lopes AC2
1School of Medicine - University of São Paulo, São Paulo, Brazil, 2CONITEC, Brasília, Brazil

PHP44
C7
MÉTODOS DE ANÁLISE MULTICRITÉRIO EMPREGADOS NA SELEÇÃO DE MEDICAMENTOS
Castro JP, Mosegui GB, Costa TM
Universidade Federal Fluminense, Niterói, Brazil

PHP45
C8
INCORPORATION OF NEW MEDICINES BY THE BRAZILIAN HEALTHCARE SYSTEM´S NATIONAL COMMITTEE FOR HEALTH TECHNOLOGY INCORPORATION, 2012 TO JUNE/2016
Biz AN1, Caetano R1, Silva RM2, Oliveira IA1, Santana PK1, Pedro ÉM1
1Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2Escola Nacional de Saúde Pública Sergio Arouca FIOCRUZ, Rio de Janeiro, Brazil

PHP46
C9
NATIONAL POLICY ON HEALTH TECHNOLOGY MANAGEMENT: A CASE STUDY OF THE NATIONAL COMMITTEE FOR TECHNOLOGY INCORPORATION, BRAZIL (CONITEC)
Yuba TY1, Novaes HM2, De Soárez PC1
1University of Sao Paulo, Sao Paulo, Brazil, 2Universidade de São Paulo, Sao Paulo, Brazil

HEALTH CARE USE & POLICY STUDIES - Population Health
PHP47
C10
EATING HABITS AND PHYSICAL EXERCISE PRACTICES OF BENEFICIARIES AND NON-BENEFICIARIES OF PRIVATE HEALTH PLANS IN BRAZIL
Nardi E1, Minami B2
1Evidencias-Kantar Health, Campinas, Brazil, 2Instituto de Estudos de Saúde Suplementar, São Paulo, Brazil

PHP48
C11
CHRONIC NON-COMMUNICABLE DISEASES (NCDS) AND BODY MASS INDEX (BMI) OF BENEFICIARIES AND NON-BENEFICIARIES OF PRIVATE HEALTH PLANS IN BRAZIL
Nardi E1, Minami B2
1Evidencias-Kantar Health, Campinas, Brazil, 2Instituto de Estudos de Saúde Suplementar, São Paulo, Brazil

PHP49
C12
WHICH ARE THE MOST COMMON QUALITY OF LIFE HEALTH STATES IN LATIN AMERICA? A PARETO ANALYSIS OF A COLLABORATIVE PROJECT USING EUROQOL EQ-5D IN ARGENTINA, BRAZIL, CHILE AND URUGUAY
Rey-Ares L1, Kind P2, Viegas M3, Zarate V4, Gianneo O5, de Souza Noronha K3, Fernandez G5, Augustovski F6
1Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, 2University of Leeds, Leeds, London, UK, 3Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 4Universidad de los Andes, Santiago, Chile, 5Fondo Nacional de Recursos, Montevideo, Uruguay, 6Universidad de Buenos Aires, Buenos Aires, Argentina

HEALTH CARE USE & POLICY STUDIES - Prescribing Behavior & Treatment Guidelines
PHP50
C13
EVALUATION OF APPROPRIATENESS OF ANTIBIOTICS IN THE INTENSIVE CARE UNIT OF A TERTIARY CARE HOSPITAL
Khatri B1, Kk S2
1Acharya and BM Reddy College of Pharmacy, Bangalore, India, 2Dr. BR Ambedkar Medical College, Bangalore, India

PHP51
C14
WITHDRAWN

HEALTH CARE USE & POLICY STUDIES - Risk Sharing/Performance-Based Agreements
PHP52
C15
ANALGESICS PRESCRIPTION PATTERN IN A SPECIALIST TEACHING HOSPITAL IN SOUTHEAST NIGERIA
Ogbonna BO, Toh H
NNAMDI AZIKIWE UNIVERSITY, AWKA, Nigeria

PHP53
C16
NOTAS TÉCNICAS E RESPOSTAS TÉCNICAS RÁPIDAS: SEU USO NAS DECISÕES JUDICIAIS EM SAÚDE.
Diniz SD, Andrade EI
Federal University of Minas Gerais, Belo Horizonte, Brazil

HEALTH CARE USE & POLICY STUDIES - Conceptual Papers
PHP54
C17
USO DE MEDICAMENTOS INAPROPRIADOS EM IDOSOS INSTITUCIONALIZADOS NO MUNICÍPIO DE SÃO PAULO, BRASIL
Chagas VO1, Assis DL2, Gorzoni ML3, Valente M3
1Universidade Federal de Goiás, Goiânia, Goiás, Brazil, 2Universidade Federal de Goiás, Jataí, Goiás, Brazil, 3Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil

PHP55
C18
JUDICIALIZAÇÃO DA SAÚDE NO BRASIL: PROXIMIDADE DOS MAGISTRADOS COM AS POLÍTICAS PÚBLICAS DE SAÚDE
Silva SN1, Gomes PT1, Catanheide ID2, Simabuku EM2, Rabelo RB3
1Ministry of Health, Brasilia, Brazil, 2Brazilian Ministry of Health, Brasilia, Brazil, 3Department of Management and Incorporation of Health Technology, National Committee for Health Technology Incorporation (CONITEC), Brazilian Ministry of Health, Brasília, Brazil

PHP56
D1
EVALUACIÓN ECONÓMICA DE MEDICAMENTOS PARA EL TRATAMIENTO DE SÍNDROME METABÓLICO DESDE LA PERSPECTIVA DE UN SISTEMA DE SALUD PRIVADO EN MEXICO
Marquez M, Granados F, Torres A, Aguilar J
Vitamédica S.A. de C.V., Ciudad de México, Mexico

PHP57
D2
DETERMINANTES DOS CUSTOS DOS PROCESSOS JUDICIAIS DE MEDICAMENTOS EM UM MUNICÍPIO DA REGIÃO CENTRO-OESTE DO BRASIL
Chagas VO, Provin MP, Amaral RG
Universidade Federal de Goiás, Goiânia, Goiás, Brazil

PHP58
D3
EXENATIDE IN OBESE OR OVERWEIGHT PATIENTS WITHOUT DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS
Su N, Xu T, Sun X
West China Hospital of Sichuan University, Chengdu, China

PHP59
D4
HEALTH ECONOMICS AND OUTCOMES RESEARCH NEEDS ASSESSMENT FOR LATIN AMERICA: RELATIONSHIP BETWEEN PERCEIVED AND EXPECTED QUALITY OF KNOWLEDGE IN A SELF-ASSESSMENT SURVEY
Hincapie A1, Azeredo-da-Silva AF2
1University of Cincinnati, Cincinnati, OH, USA, 2Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

PHP60
D5
RISK SHARING AGREEMENTS AS PAYMENT MECHANISMS: A COMPREHENSIVE AND COMMUNICABLE PRACTICAL APPROACH FOR STAKEHOLDERS.
Paredes Fernandez D1, Quirland-Lazo C1, Lenz Alcayaga R2
1Universidad de Chile, Santiago, Chile, 2Lenz Consultores, Santiago, Chile

PHP61
D6
IMPACTO DE UNA LEY DE BIOEQUIVALENCIA EN EL PRECIO DE MEDICAMENTOS
Silva NS, Guerrero C
University of Chile, Santiago, Chile

PHP62
D7
PLAN DE ATENCION DE CUIDADOS PALIATIVOS Y CUIDADOS DE FIN DE VIDA
Fernandez JC, Romero Buelvas A
MUTUALSER EPS, PHAROS CENTRO DE ESTUDIOS CLINICOS, CARTAGENA DE INDIAS, Colombia

PHP63
D8
DETECCIÓN TEMPRANA DEL CÁNCER DE PULMÓN
Fernandez JC, Remolina Medina C
MUTUALSER EPS, PHAROS CENTRO DE ESTUDIOS CLINICOS, CARTAGENA DE INDIAS, Colombia

PHP64
D9
ESTRATÉGIAS INTITUCIONAIS COMO MECANISMO DE RACIONALIZAÇÃO DAS DEMANDAS JUDICIAIS DE MEDICAMENTOS
Chagas VO, Provin MP, Amaral RG
Universidade Federal de Goiás, Goiânia, Goiás, Brazil

PHP65
D10
ACCESSIBILITY TO ONCOLOGIC TREATMENT IN SUS PUBLIC HEALTH SYSTEMS AND OBAMACARE.
Rodrigues S, Gomes L
Universidade de São Paulo, São Paulo, Brazil

PHP66
D11
A VIA ADMINISTRATIVA E JUDICIAL COMO FORMA DE ACESSO AOS MEDICAMENTOS NO SISTEMA PÚBLICO DE SAÚDE BRASILEIRO
Chagas VO, Provin MP, Amaral RG
Universidade Federal de Goiás, Goiânia, Goiás, Brazil

PHP67
D12
PRACTICAL CONSIDERATIONS FOR A DIALYSIS PROVISION MODEL OF CARE FOR END-STAGE RENAL DISEASE (ESRD). BENCHMARK OF INTERNATIONAL EXPERIENCES, OPPORTUNITIES FOR THE MEXICAN SOCIAL SECURITY INSTITUTE (IMSS)
Brabata C
BAXTER, MIAMI, FL, USA

PHP68
D13
EVALUACIÓN DE PERTINENCIA CIENTÍFICA Y ANÁLISIS DE COSTO-EFECTIVIDAD EN LAS INTERVENCIONES DE SALUD
Fernandez JC1, Failach Zubiria C2
1MUTUALSER EPS, PHAROS CENTRO DE ESTUDIOS CLINICOS, CARTAGENA DE INDIAS, Colombia, 2MUTUALSER EPS, CARTAGENA DE INDIAS, Colombia

PHP69
D14
THE IMPORTANCE OF THE DISINVESTMENT PROCESS IN THE PUBLIC HEALTH SYSTEM
Correa JS1, Chabrol Haas L2, Vasconcellos JF3, Santiago IC4
1Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2MSD Brasil, São Paulo, Brazil, 3Sense Company, Rio de Janeiro, Brazil, 4Instituto Nacional de Cardiologia, Rio de Janeiro, Brazil

PHP70
D15
UN MARCO CONCEPTUAL PARA EL ANÁLISIS DE LA IMPLEMENTACIÓN DE LOS COMPONENTES DE LA SALUD ELECTRÓNICA (E-SALUD) Y SU EFECTO EN LA CALIDAD EN LA PROVISIÓN DE SERVICIOS DE SALUD
Díaz de León C
Consejo Nacional de Ciencia y Tecnología - Infotec, Aguascalientes, Mexico

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.